20, AVENUE APPIA – CH-1211 GENEVA 27 – SWITZERLAND – TEL CENTRAL +41 22 791 2111 – FAX CENTRAL +41 22 791 3111 – WWW.WHO.INT
Ref.: C.L.19.2019
The World Health Organization (WHO) presents its compliments to Member States and
has the honour to inform them that the draft Global Strategy for Tuberculosis (TB) Research and
Innovation (the Global Strategy) is open for public consultation. The draft Global Strategy for
TB Research and Innovation is being prepared in response to a request made to the Director-
General in resolution WHA71.3.
Tuberculosis is the leading cause of death from a single infectious agent globally exacting
heavy morbidity, mortality, and economic cost in many countries around the globe. The WHO
End TB Strategy adopted by Member States in 2014 stipulates that major technological
breakthroughs are needed by 2025, in order to immediately accelerate the fall of TB incidence.
To achieve these goals, Member States made a commitment in the political declaration of the
United Nations General Assembly High-Level Meeting on the fight against TB in
September 2018 to develop and diffuse more effective medical innovations and strategies.
In this context, the Global Strategy for TB Research and Innovation aims to support efforts
by Member States to accelerate research and innovation, by setting clear objectives and priorities
for advancing the science required to end TB. This consultation will allow WHO to have a better
understanding of how the elements of the Global Strategy can best inform and support national
TB research and innovation strategies and actions to drive impact in TB prevention and care.
The consultation will be facilitated through a public web platform:
https://www.who.int/tb/areas-of-work/research/en/. Member States are invited to review the
Global Strategy and submit their comments by Wednesday, 8 May 2019. Civil society and other
partners will also be reviewing and providing comments. WHO will make available all the
comments received on the above-mentioned website.
Questions pertaining to this process can be addressed to
[email protected].
Based on the comments received on this draft, WHO will prepare a revised draft of the
strategy, such that it can be considered by the regional committees in line with decision
WHA65(9), which decides “that regional committees be asked to comment and provide input to
all global strategies, policies and legal instruments such as conventions, regulations and codes”,
before it is submitted for consideration by the Executive Board at its 146th session in
January 2020
The World Health Organization takes this opportunity to renew to Member States the
assurance of its highest consideration.
GENEVA, 29 March 2019
Saatja: <
[email protected]>
Saadetud: 29.03.2019 16:44
Koopia: <
[email protected]>; <
[email protected]>; <
[email protected]>
Teema: WHO: C.L.19.2019 (TB consultation)
Dear Member States of the World Health Organization,Please find attached,
in the six official languages, C.L.19.2019 regarding the consultation of
the draft Global Strategy for Tuberculosis Research and Innovation.Best
regards,Department of Governing BodiesWorld Health Organization